You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sorafenib

Showing 1 - 25 of 1,094
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pharmacokinetics, Bioavailability Trial in Nottingham (Sorafenib - Period 1, XS005 Sorafenib Capsule A - Period 1, XS005

Completed
  • Pharmacokinetics
  • Bioavailability
  • Sorafenib - Period 1
  • +8 more
  • Nottingham, United Kingdom
    Quotient Sciences
Jul 20, 2023

Hepatocellular Carcinoma Trial in Mansoura (Sorafenib Tablets)

Recruiting
  • Hepatocellular Carcinoma
  • Sorafenib Tablets
  • Mansoura, El-Dakahelia, Egypt
    Mansoura University Hospital
Sep 3, 2023

Hepatocellular Carcinoma Trial (The neutrophil-to- lymphocyte ratio, Prognostic nutrition index)

Not yet recruiting
  • Hepatocellular Carcinoma
  • The neutrophil-to- lymphocyte ratio
  • Prognostic nutrition index
  • (no location specified)
Jul 28, 2023

Advanced Hepatocellular Carcinoma Trial (Sorafenib)

Enrolling by invitation
  • Advanced Hepatocellular Carcinoma
  • Sorafenib
  • Seoul, Korea, Republic of
    National Cancer Center, Korea
Oct 19, 2022

Hepatocellular Cancer Trial in San Antonio (Sorafenib (SOR), Hydroxychloroquine (HCQ))

Recruiting
  • Hepatocellular Cancer
  • Sorafenib (SOR)
  • Hydroxychloroquine (HCQ)
  • San Antonio, Texas
    University of Texas Health Cancer Center
Sep 16, 2022

Hepatocellular Carcinoma, Advanced Cancer Trial in Charleston, Tainan, Taipei (Sorafenib, CVM-1118)

Terminated
  • Hepatocellular Carcinoma
  • Advanced Cancer
  • Charleston, South Carolina
  • +2 more
Jan 6, 2023

Called ROCURS, to Learn About COVID-19 Related Outcomes in

Active, not recruiting
  • Malignant Solid Tumors
  • +2 more
  • Whippany, New Jersey
    Bayer
Feb 2, 2023

The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or

Recruiting
  • Acute Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Sorafenib
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 28, 2022

Prospective, Non-interventional, Post-authorization Safety Study

Active, not recruiting
  • Thyroid Carcinoma
  • Sorafenib (Nexavar, BAY43-9006)
  • Multiple Locations, Japan
    (unnamed)
Aug 18, 2022

Advanced Cancer Trial in Houston (Temsirolimus, Bevacizumab, Paclitaxel)

Active, not recruiting
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 11, 2022

Hepatocellular Carcinoma Trial in Shanghai (IBI310, Sintilimab, Sorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • Shanghai, Shanghai, China
    Fudan Universtiy Zhongshan Hospital
Sep 16, 2022

The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Sorafenib
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022

The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Sorafenib
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022

Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)

Recruiting
  • Refractory Solid Tumor
  • +4 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 4, 2022

Hepatocellular Carcinoma Trial in Dhaka (Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Dhaka, Bangladesh
  • +1 more
May 21, 2022

Neuroblastoma Trial in Canada, United States (Sorafenib, Cyclophosphamide, Topotecan)

Active, not recruiting
  • Neuroblastoma
  • Sorafenib
  • +2 more
  • Los Angeles, California
  • +11 more
Jan 30, 2023

Thyroid Cancer Trial in United States (sorafenib with everolimus)

Active, not recruiting
  • Thyroid Cancer
  • sorafenib with everolimus
  • Basking Ridge, New Jersey
  • +3 more
Jul 1, 2022

Hepatocellular Carcinoma, Hepatitis B, Hepatitis C Trial in Duarte, Singapore (MTL-CEBPA, Sorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Duarte, California
  • +1 more
Feb 20, 2022

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (TACE combined with sorafenib and tislelizumab)

Completed
  • Hepatocellular Carcinoma Non-resectable
  • TACE combined with sorafenib and tislelizumab
  • Guangzhou, Guangdong, China
  • +1 more
Oct 11, 2022

Advanced Solid Tumors, Hepatocellular Carcinoma Trial in Chiba, Etc. (BBI503, Sorafenib)

Completed
  • Advanced Solid Tumors
  • Hepatocellular Carcinoma
  • Chiba, Etc., Japan
    5 Sites
Apr 9, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • sorafenib tosylate
  • +4 more
  • Aurora, Colorado
  • +1 more
Sep 8, 2022

Melanoma (Skin) Trial in Philadelphia (sorafenib tosylate, temozolomide)

Completed
Has Results
  • Melanoma (Skin)
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jun 13, 2022

Hepatocellular Carcinoma Trial (Irinotecan, Sonidegib, Sorafenib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Dec 20, 2022

Prostate Cancer Trial in Philadelphia (docetaxel, sorafenib tosylate)

Completed
Has Results
  • Prostate Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Feb 16, 2022

Core Binding Factor Acute Myeloid Leukemia Trial in Guangzhou (Sorafenib, Idarubicin, Cytarabine)

Recruiting
  • Core Binding Factor Acute Myeloid Leukemia
  • Sorafenib
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
May 31, 2022